Proteomic profiling of germ cell cancer cells treated with aaptamine, a marine alkaloid with antiproliferative activity.

Standard

Proteomic profiling of germ cell cancer cells treated with aaptamine, a marine alkaloid with antiproliferative activity. / Dyshlovoy, Sergey A.; Naeth, Ina; Venz, Simone; Preukschas, Michael; Sievert, Henning; Jacobsen, Christine; Shubina, Larisa K; Manuela, Gesell Salazar; Scharf, Christian; Walther, Reinhard; Krepstakies, Marcel; Priyadarshini, Poornima; Hauber, Joachim; Fedorov, Sergey N; Bokemeyer, Carsten; Stonik, Valentin A; Balabanov, Stefan; Honecker, Friedemann.

In: J PROTEOME RES, Vol. 11, No. 4, 4, 2012, p. 2316-2330.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

Dyshlovoy, SA, Naeth, I, Venz, S, Preukschas, M, Sievert, H, Jacobsen, C, Shubina, LK, Manuela, GS, Scharf, C, Walther, R, Krepstakies, M, Priyadarshini, P, Hauber, J, Fedorov, SN, Bokemeyer, C, Stonik, VA, Balabanov, S & Honecker, F 2012, 'Proteomic profiling of germ cell cancer cells treated with aaptamine, a marine alkaloid with antiproliferative activity.', J PROTEOME RES, vol. 11, no. 4, 4, pp. 2316-2330. <http://www.ncbi.nlm.nih.gov/pubmed/22409352?dopt=Citation>

APA

Dyshlovoy, S. A., Naeth, I., Venz, S., Preukschas, M., Sievert, H., Jacobsen, C., Shubina, L. K., Manuela, G. S., Scharf, C., Walther, R., Krepstakies, M., Priyadarshini, P., Hauber, J., Fedorov, S. N., Bokemeyer, C., Stonik, V. A., Balabanov, S., & Honecker, F. (2012). Proteomic profiling of germ cell cancer cells treated with aaptamine, a marine alkaloid with antiproliferative activity. J PROTEOME RES, 11(4), 2316-2330. [4]. http://www.ncbi.nlm.nih.gov/pubmed/22409352?dopt=Citation

Vancouver

Bibtex

@article{d2a5ec0b731843f4883c143fb9a93c59,
title = "Proteomic profiling of germ cell cancer cells treated with aaptamine, a marine alkaloid with antiproliferative activity.",
abstract = "Aaptamine is a marine compound isolated from the sponge Aaptos aaptos showing antiproliferative properties via an undefined mode of action. We analyzed the effects of aaptamine treatment on the proliferation and protein expression of the pluripotent human embryonal carcinoma cell line NT2. Effects on proliferation, cell cycle distribution, and induction of apoptosis were analyzed. At lower concentrations, including the IC50 of 50 ?M, aaptamine treatment resulted in a G2/M phase cell cycle arrest, whereas at higher concentrations, induction of apoptosis was seen. Differentially expressed proteins were assessed by 2D-PAGE and mass spectrometry, followed by verification and analysis of protein modifications of the most significantly up- and down-regulated proteins. Aaptamine treatment at the IC50 for 48 h resulted in alteration of 10 proteins, of which five each showed up- and down-regulation. Changes in the 2D map were frequently noticed as a result of post-transcriptional modifications, e.g., of the hypusine modification of the eukaryotic initiation factor 5A (eIF5A). Observed alterations such as increased expression of CRABP2 and hypusination of eIF5A have previously been identified during differentiation of pluripotent cells. For the first time, we describe changes in protein expression caused by aaptamine, providing valuable information regarding the mode of action of this compound.",
keywords = "Humans, Reproducibility of Results, Cell Line, Tumor, Amino Acid Sequence, Molecular Sequence Data, Dose-Response Relationship, Drug, HEK293 Cells, Cell Proliferation/drug effects, Cell Survival/drug effects, Proteomics/methods, Electrophoresis, Gel, Two-Dimensional, Lysine/analogs & derivatives/metabolism, Antineoplastic Agents/*pharmacology, Peptide Initiation Factors/metabolism, RNA-Binding Proteins/metabolism, Cell Cycle Checkpoints/drug effects, Biological Agents/pharmacology, Naphthyridines/*pharmacology, Neoplasms, Germ Cell and Embryonal/*chemistry/*drug therapy/metabolism/pathology, Oxidoreductases Acting on CH-NH Group Donors/genetics/metabolism, Proteins/analysis/genetics/metabolism, Proteome/analysis/*drug effects/genetics/metabolism, Humans, Reproducibility of Results, Cell Line, Tumor, Amino Acid Sequence, Molecular Sequence Data, Dose-Response Relationship, Drug, HEK293 Cells, Cell Proliferation/drug effects, Cell Survival/drug effects, Proteomics/methods, Electrophoresis, Gel, Two-Dimensional, Lysine/analogs & derivatives/metabolism, Antineoplastic Agents/*pharmacology, Peptide Initiation Factors/metabolism, RNA-Binding Proteins/metabolism, Cell Cycle Checkpoints/drug effects, Biological Agents/pharmacology, Naphthyridines/*pharmacology, Neoplasms, Germ Cell and Embryonal/*chemistry/*drug therapy/metabolism/pathology, Oxidoreductases Acting on CH-NH Group Donors/genetics/metabolism, Proteins/analysis/genetics/metabolism, Proteome/analysis/*drug effects/genetics/metabolism",
author = "Dyshlovoy, {Sergey A.} and Ina Naeth and Simone Venz and Michael Preukschas and Henning Sievert and Christine Jacobsen and Shubina, {Larisa K} and Manuela, {Gesell Salazar} and Christian Scharf and Reinhard Walther and Marcel Krepstakies and Poornima Priyadarshini and Joachim Hauber and Fedorov, {Sergey N} and Carsten Bokemeyer and Stonik, {Valentin A} and Stefan Balabanov and Friedemann Honecker",
year = "2012",
language = "English",
volume = "11",
pages = "2316--2330",
journal = "J PROTEOME RES",
issn = "1535-3893",
publisher = "American Chemical Society",
number = "4",

}

RIS

TY - JOUR

T1 - Proteomic profiling of germ cell cancer cells treated with aaptamine, a marine alkaloid with antiproliferative activity.

AU - Dyshlovoy, Sergey A.

AU - Naeth, Ina

AU - Venz, Simone

AU - Preukschas, Michael

AU - Sievert, Henning

AU - Jacobsen, Christine

AU - Shubina, Larisa K

AU - Manuela, Gesell Salazar

AU - Scharf, Christian

AU - Walther, Reinhard

AU - Krepstakies, Marcel

AU - Priyadarshini, Poornima

AU - Hauber, Joachim

AU - Fedorov, Sergey N

AU - Bokemeyer, Carsten

AU - Stonik, Valentin A

AU - Balabanov, Stefan

AU - Honecker, Friedemann

PY - 2012

Y1 - 2012

N2 - Aaptamine is a marine compound isolated from the sponge Aaptos aaptos showing antiproliferative properties via an undefined mode of action. We analyzed the effects of aaptamine treatment on the proliferation and protein expression of the pluripotent human embryonal carcinoma cell line NT2. Effects on proliferation, cell cycle distribution, and induction of apoptosis were analyzed. At lower concentrations, including the IC50 of 50 ?M, aaptamine treatment resulted in a G2/M phase cell cycle arrest, whereas at higher concentrations, induction of apoptosis was seen. Differentially expressed proteins were assessed by 2D-PAGE and mass spectrometry, followed by verification and analysis of protein modifications of the most significantly up- and down-regulated proteins. Aaptamine treatment at the IC50 for 48 h resulted in alteration of 10 proteins, of which five each showed up- and down-regulation. Changes in the 2D map were frequently noticed as a result of post-transcriptional modifications, e.g., of the hypusine modification of the eukaryotic initiation factor 5A (eIF5A). Observed alterations such as increased expression of CRABP2 and hypusination of eIF5A have previously been identified during differentiation of pluripotent cells. For the first time, we describe changes in protein expression caused by aaptamine, providing valuable information regarding the mode of action of this compound.

AB - Aaptamine is a marine compound isolated from the sponge Aaptos aaptos showing antiproliferative properties via an undefined mode of action. We analyzed the effects of aaptamine treatment on the proliferation and protein expression of the pluripotent human embryonal carcinoma cell line NT2. Effects on proliferation, cell cycle distribution, and induction of apoptosis were analyzed. At lower concentrations, including the IC50 of 50 ?M, aaptamine treatment resulted in a G2/M phase cell cycle arrest, whereas at higher concentrations, induction of apoptosis was seen. Differentially expressed proteins were assessed by 2D-PAGE and mass spectrometry, followed by verification and analysis of protein modifications of the most significantly up- and down-regulated proteins. Aaptamine treatment at the IC50 for 48 h resulted in alteration of 10 proteins, of which five each showed up- and down-regulation. Changes in the 2D map were frequently noticed as a result of post-transcriptional modifications, e.g., of the hypusine modification of the eukaryotic initiation factor 5A (eIF5A). Observed alterations such as increased expression of CRABP2 and hypusination of eIF5A have previously been identified during differentiation of pluripotent cells. For the first time, we describe changes in protein expression caused by aaptamine, providing valuable information regarding the mode of action of this compound.

KW - Humans

KW - Reproducibility of Results

KW - Cell Line, Tumor

KW - Amino Acid Sequence

KW - Molecular Sequence Data

KW - Dose-Response Relationship, Drug

KW - HEK293 Cells

KW - Cell Proliferation/drug effects

KW - Cell Survival/drug effects

KW - Proteomics/methods

KW - Electrophoresis, Gel, Two-Dimensional

KW - Lysine/analogs & derivatives/metabolism

KW - Antineoplastic Agents/pharmacology

KW - Peptide Initiation Factors/metabolism

KW - RNA-Binding Proteins/metabolism

KW - Cell Cycle Checkpoints/drug effects

KW - Biological Agents/pharmacology

KW - Naphthyridines/pharmacology

KW - Neoplasms, Germ Cell and Embryonal/chemistry/drug therapy/metabolism/pathology

KW - Oxidoreductases Acting on CH-NH Group Donors/genetics/metabolism

KW - Proteins/analysis/genetics/metabolism

KW - Proteome/analysis/drug effects/genetics/metabolism

KW - Humans

KW - Reproducibility of Results

KW - Cell Line, Tumor

KW - Amino Acid Sequence

KW - Molecular Sequence Data

KW - Dose-Response Relationship, Drug

KW - HEK293 Cells

KW - Cell Proliferation/drug effects

KW - Cell Survival/drug effects

KW - Proteomics/methods

KW - Electrophoresis, Gel, Two-Dimensional

KW - Lysine/analogs & derivatives/metabolism

KW - Antineoplastic Agents/pharmacology

KW - Peptide Initiation Factors/metabolism

KW - RNA-Binding Proteins/metabolism

KW - Cell Cycle Checkpoints/drug effects

KW - Biological Agents/pharmacology

KW - Naphthyridines/pharmacology

KW - Neoplasms, Germ Cell and Embryonal/chemistry/drug therapy/metabolism/pathology

KW - Oxidoreductases Acting on CH-NH Group Donors/genetics/metabolism

KW - Proteins/analysis/genetics/metabolism

KW - Proteome/analysis/drug effects/genetics/metabolism

M3 - SCORING: Journal article

VL - 11

SP - 2316

EP - 2330

JO - J PROTEOME RES

JF - J PROTEOME RES

SN - 1535-3893

IS - 4

M1 - 4

ER -